Immune Therapeutics Stock Forecast, Price & News

Immune Therapeutics (OTCMKTS:IMUN) Frequently Asked Questions

How has Immune Therapeutics' stock price been impacted by Coronavirus?

Immune Therapeutics' stock was trading at $0.0064 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, IMUN stock has increased by 26,618.8% and is now trading at $1.71.
View which stocks have been most impacted by COVID-19.

Who are Immune Therapeutics' key executives?

Immune Therapeutics' management team includes the following people:

• Kevin J. Phelps, President, Chief Executive Officer, CFO & Director
• Rudy J. Williams, Chief Operating Officer
• Fengping Shan, Chief Science Officer
• Joseph M. Fortunak, Vice President-Global Research & Development
• Kathleen A. Browne, Controller

Who are some of Immune Therapeutics' key competitors?

Some companies that are related to Immune Therapeutics include Amarantus BioScience (AMBS), Boston Therapeutics (BTHE), Kaya (KAYS), Kaya (KAYS), CannaPharmaRX (CPMD), Bioxytran (BIXT), ImmunoCellular Therapeutics (IMUC), VIVUS (VVUSQ), ImmunoCellular Therapeutics (IMUCD), American Bio Medica (ABMC), Global Future City (FTCY), Inspyr Therapeutics (NSPX), Adhera Therapeutics (ATRX), Capstone Therapeutics (CAPS) and Skinvisible (SKVI).
View all of IMUN's competitors.

What other stocks do shareholders of Immune Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Immune Therapeutics investors own include Northwest Biotherapeutics (NWBO), Alexion Pharmaceuticals (ALXN), AK Steel (AKS), Galiano Gold (AKG), Agritek (AGTK), Agenus (AGEN), Affymetrix (AFFX), Advanced Disposal Services (ADSW), Adamis Pharmaceuticals (ADMP) and Analog Devices (ADI).

What is Immune Therapeutics' stock symbol?

Immune Therapeutics trades on the OTCMKTS under the ticker symbol "IMUN."

How do I buy shares of Immune Therapeutics?

Shares of IMUN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Immune Therapeutics' stock price today?

One share of IMUN stock can currently be purchased for approximately $1.71.

How much money does Immune Therapeutics make?

Immune Therapeutics has a market capitalization of $820.80 thousand and generates $110 thousand in revenue each year. The company earns $1.59 million in net income (profit) each year or ($61.94) on an earnings per share basis.

How many employees does Immune Therapeutics have?

Immune Therapeutics employs 2 workers across the globe.

What is Immune Therapeutics' official website?

The official website for Immune Therapeutics is www.immunetherapeutics.com.

Where are Immune Therapeutics' headquarters?

Immune Therapeutics is headquartered at 37 NORTH ORANGE AVENUE SUITE 800M, WINTER PARK FL, 32792.

How can I contact Immune Therapeutics?

Immune Therapeutics' mailing address is 37 NORTH ORANGE AVENUE SUITE 800M, WINTER PARK FL, 32792. The company can be reached via phone at (888) 613-8802 or via email at [email protected].